ASBP
NASDAQ · Pharmaceuticals
Aspire Biopharma Holdings In
$8.09
+1.33 (+19.67%)
Open$6.73
Previous Close$6.76
Day High$8.32
Day Low$6.70
52W High$432.00
52W Low—
Volume—
Avg Volume22.1K
Market Cap11.35M
P/E Ratio—
EPS$-121.90
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 174.5K | 2.20M | 2.09M |
| Net Income | -689,058,573 | 266.8K | 312.0K |
| Profit Margin | -394,852.4% | 12.1% | 14.9% |
| EBITDA | -554,926,158 | 501.0K | 520.7K |
| Free Cash Flow | — | 197.3K | 259.9K |
| Rev Growth | — | +5.7% | +22.2% |
| Debt/Equity | 0.00 | 0.42 | 0.41 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |